About

With remarkable advances in genomic technologies, the National Cancer Institute established the Core Genotyping Facility (CGF) to investigate the contribution of germline genetic variation to cancer susceptibility and outcomes. Working in concert with epidemiologists, biostatisticians and basic research scientists in the intramural research program, the CGF has developed the capacity to conduct genome-wide association studies and candidate gene approaches to identify the heritable determinants of various forms of cancer.

Affiliations

The Core Genotyping Facility (CGF) is within the the Division of Cancer Epidemiology and Genetics (DCEG) of the National Cancer Institute (NCI) and supported by SAIC-Frederick. The staff are members of the Advanced Technology Program (ATP) of SAIC-Frederick.